These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

984 related items for PubMed ID: 15669149

  • 21. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC, Brown LE, Stone PH, Silverman DI, Gibson CM, Sacks FM.
    Ann Intern Med; 1996 Oct 01; 125(7):529-40. PubMed ID: 8815751
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Impact of the attainment of current recommended low-density lipoprotein cholesterol goal of less than 70 mg/dl on clinical outcomes in very high-risk patients treated with drug-eluting stents.
    Kim BK, Kim DW, Oh S, Yoon SJ, Park S, Jeon DW, Yang JY.
    Coron Artery Dis; 2010 May 01; 21(3):182-8. PubMed ID: 20168221
    [Abstract] [Full Text] [Related]

  • 24. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG, Paterson JR.
    QJM; 2000 Sep 01; 93(9):567-74. PubMed ID: 10984551
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization.
    Valuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, Ensor JE.
    Clin Ther; 2003 Nov 01; 25(11):2936-57. PubMed ID: 14693317
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.
    Sukonthasarn A, Homsanit M, Prommete B, Chotinaiwattarakul C, Piamsomboon C, Likittanasombat K.
    J Med Assoc Thai; 2011 Dec 01; 94(12):1424-34. PubMed ID: 22295727
    [Abstract] [Full Text] [Related]

  • 30. Optimizing LDL-C lowering with statins.
    McKenney JM.
    Am J Ther; 2004 Dec 01; 11(1):54-9. PubMed ID: 14704596
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.
    Teramoto T, Uno K, Miyoshi I, Khan I, Gorcyca K, Sanchez RJ, Yoshida S, Mawatari K, Masaki T, Arai H, Yamashita S.
    Atherosclerosis; 2016 Aug 01; 251():248-254. PubMed ID: 27419905
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J, Rouyer MV, Lautsch D, Ashton V, Ambegaonkar BM, Brudi P, Gitt AK, Dyslipidemia International Study (DYSIS) II France Study Group.
    Arch Cardiovasc Dis; 2017 Mar 01; 110(3):167-178. PubMed ID: 28209375
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cholesterol: precursor to many lipid disorders.
    Jones PH.
    Am J Manag Care; 2001 Aug 01; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.